C4 Therapeutics, Inc. (CCCC) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $359.07M | +2.7% |
| 2024 | $349.60M | -7.1% |
| 2023 | $376.45M | -12.6% |
| 2022 | $430.84M | -15.0% |
| 2021 | $506.76M | +26.6% |
| 2020 | $400.14M | +238.4% |
| 2019 | $118.26M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $359.07M | +2.7% |
| 2024 | $349.60M | -7.1% |
| 2023 | $376.45M | -12.6% |
| 2022 | $430.84M | -15.0% |
| 2021 | $506.76M | +26.6% |
| 2020 | $400.14M | +238.4% |
| 2019 | $118.26M | — |